CD79A and infection: The plasma IgA response to SARS‐CoV‐2 is relatively transient in nature peaking during acute infection and dominates the acute plasma neutralising response (half‐life of 42 days in the first 60 days and > 1000 days from 60–160‐day postsymptom onset).2, 19